verapamil has been researched along with Glycogen Storage Disease in 3 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Glycogen Storage Disease: A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalized storage of glycogen occurs, sometimes with prominent cardiac involvement.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eleven patients, comprising three cases of McArdle's disease and eight with an exertional muscle pain syndrome (EMPS) of unknown cause, entered a double-blind crossover study of verapamil and placebo." | 9.06 | A double-blind, placebo-controlled, crossover study of verapamil in exertional muscle pain. ( Lane, RJ; Turnbull, DM; Walton, J; Welch, JL, 1986) |
| "Eleven patients, comprising three cases of McArdle's disease and eight with an exertional muscle pain syndrome (EMPS) of unknown cause, entered a double-blind crossover study of verapamil and placebo." | 5.06 | A double-blind, placebo-controlled, crossover study of verapamil in exertional muscle pain. ( Lane, RJ; Turnbull, DM; Walton, J; Welch, JL, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lane, RJ | 2 |
| Turnbull, DM | 2 |
| Hudgson, P | 1 |
| Walton, J | 2 |
| Sakaguchi, S | 1 |
| Ibata, H | 1 |
| Yokota, K | 1 |
| Welch, JL | 1 |
2 trials available for verapamil and Glycogen Storage Disease
| Article | Year |
|---|---|
Trials of verapamil and dantrolene sodium in McArdle disease.
Topics: Calcium; Clinical Trials as Topic; Dantrolene; Glycogen Storage Disease; Glycogen Storage Disease Ty | 1984 |
A double-blind, placebo-controlled, crossover study of verapamil in exertional muscle pain.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Glycogen Storage Disease; Glycogen Sto | 1986 |
1 other study available for verapamil and Glycogen Storage Disease
| Article | Year |
|---|---|
Participation of calcium ion on depletion mechanism of liver glycogen by purified glucocorticoid antagonizing factor released in blood during endotoxemia.
Topics: Animals; Calcium; Cortisone; Enterotoxemia; Glycogen Storage Disease; Glycogen Synthase; Glycoprotei | 1990 |